Click here to jump to body content.Click here to visit the U of M website.
School of Public Health
HOME | PRINT  
Whats Inside

About SPH

Education

Prospective Students

Current Students

Faculty & Research

Alumni

Search SPH







University of Minnesota and the School of Public Health

Faculty

Faculty who are involved with the M.S. program join an official Graduate School group titled a "graduate faculty body."  The Clinical Research MS graduate faculty body currently consists of 53 faculty members. Additional faculty will be added as the program needs grow and specific skills are required.

The major draws faculty from the University's schools of public health, medicine, dentistry, nursing, pharmacy, and veterinary medicine.  Faculty interests range over a broad set of topics.  The following table lists areas of research expertise for full-time and adjunct faculty.           

CR Faculty/Home Department

Research Interests

K. Scott Baker MD, MS
Hematology/Oncology; Pediatrics

Long-term complications in survivors of childhood cancer or after hematopoietic stem cell transplantation

Gregory Beilman, MD, FACS
Surgical Critical Care; Surgery

Tissue energetics in hemorrhagic and septic shock; new monitoring strategies in the ICU; Novel treatments of sepsis; outcomes in ICU and surgical infections

Alan Berger, MD
Cardiology: Medicine with an Adjunct Appointment with Epidemiology and Community Health

Acute coronary syndromes and interventional catheterization. Utilization of reperfusion therapy for acute myocardial infarctions.

Carole Bland, PhD
Family Practice/Community Health; Medical School

Individual and institutional characteristics of research productivity, faculty development and educational program evaluation

Donna Bliss, PhD, RN, FAAN
Nursing

Effects of dietary fiber therapies on fecal incontinence; nutrition support - dietary fiber, tube feeding and diarrhea; prevention of perineal dermatitis associated with incontinence

Hanna Bloomfield, MD, MPH
General Internal Medicine; VA Medical Center

Health services and outcomes research, chronic disease, cardiovascular disease prevention and clinical trials

Paul Bohjanen, MD, PhD
Microbiology Department

T Lymphocyte mRNA Stability. Research focuses on the role of mRNA decay in regulating T lymphocyte activation and function.

John Bond, MD
Medicine, VA Medical Center

Colorectal cancer

Linda Burns, MD
Hematology, Oncology, Transplantation; Medicine

Clinical trials research; hematopoietic stem cell transplantation; hematologic malignancies; immunotherapy

Jay N. Cohn, MD
Cardiovascular Division, Rasmussen Center for Cardiovascular Disease Prevention

Congestive heart failure diagnosis and treatment, hypertension, early detection of CV disease, arterial compliance

Allan Collins, MD
Renal Diseases and Hypertension; Medicine; Director, Chronic Disease Research Group, Minneapolis Medical Research Foundation

Observational studies using large registry databases for kidney disease patients; causes and consequences of anemia and other complications of end-stage renal disease

Daniel Duprez, MD, PhD
Cardiology; Medicine

Clinical trials cardiology, primary and secondary prevention, arterial stiffness, lipid disorders, arterial hypertension, peripheral vascular disease, cardiovascular risk scores. New techniques for early detection of cardiovascular disease

Maurice Dysken, MD
Psychiatry; GRECC Program, VA Medical Center

Clinical trials with Alzheimer patients for treatment of cognitive impairment and/or behavioral problems:  delirium assessment and prevention

Kristine Ensrud, MD, MPH
Epidemiology/Medicine; VA Medical Center

Epidemiology of chronic diseases with focus in osteoporosis prevention and treatment, management of menopausal symptom, sleep disorders

Patricia Fontaine, MD, MS
Family Practice/Community Health; Medical School

Cervical cancer screening.  Perinatal and newborn care, including pain management for labor.  Practice-based research networks.

Edward Greeno, MD
Hematology, Oncology, Transplantation; Medicine

Clinical trials involving prevention of thrombosis and in active treatment of solid tumor malignancies

Richard Grimm, MD, PhD
Berman Center; Hennepin County Medical Center

Clinical trials on hypertension, lipids, CV risk; women’s Health and complementary and alternative medicine

David Hardten, MD
Ophthalmology; Medical School

Diseases of the eye

Dorothy Hatsukami, PhD
Psychiatry; Medical School

Behavioral pharmacology and treatment of nicotine addiction; toxicity of tobacco products

Timothy D. Henry, MD
Interventional Cardiology, Director of Research, Minneapolis Heart Institute Foundation

Acute myocardial infarction, interventional cardiology, angiogenesis, stem cell research, clinical trials

Alan T. Hirsch, MD
Vascular Medicine and Cardiology; Epidemiology and Community Health; School of Public Health; Medical School; and Minneapolis Heart Institute Foundation

Epidemiology of peripheral arterial disease (PAD); clinical trials of PAD pharmacotherapies, endovascular interventions, and tobacco cessation interventions to improve non-coronary vascular outcomes; clinical trials of lipid and hypertension cardiovascular risk reduction interventions; evaluation of quality-of-life in vascular diseases; health economics of PAD.

Andrew Huang, MD
Ophthalmology; Medical School

Corneal diseases

Hassan Ibrahim, MD, MS
Renal Diseases and Hypertension; Medicine

Clinical research in progressive renal disease, diabetic nephropathy and chronic renal transplant rejection

Ajay Israni, MD, MS
Renal Division, Department of Medicine

Molecular epidemiology and renal transplantation, outcomes in renal transplantation and end-stage renal disease

Jeffrey Kahn, PhD, MPH
Center for Bioethics

Bioethics, including ethics of human subject research, ethics and genetics, ethics and biotechnology, ethics and public health

Joseph Keenan, MD
Family Practice/Community Health; Medical School

Cardiovascular heart disease, home care and nutrition

Nigel Key, MB, ChB, FRCP
Hematology, Oncology, Transplantation; Medicine

Hemostasis and thrombosis

Robert Kratzke, MD
Medicine, Hematology Office

Molecular abnormalities in lung cancer and mesothelioma, focusing primarily on cell cycle regulator genes and their loss of function in cancer.

Frank A. Lederle, MD
Medicine; VA Medical Center

Management of abdominal aortic aneurysms, evidence-based medical decision-making, clinical trial methodology

John Look, DDS, MPH, PhD
Diagnostic and Biological Sciences

Temporomandibular joint disorders

Russell Luepker, MD, MS
Epidemiology and Community Health; Public Health

Cardiovascular disease epidemiology and clinical trials

Karen Margolis, MD, MPH
HealthPartners Research Foundation

Cardiovascular disease epidemiology and prevention, women’s health, diabetes epidemiology, prevention and treatment

Philip McGlave, MD
Medicine

Experimental therapy for malignant and non-malignant hematologic disorders including stem cell transplantation, immunotherapy, and gene transfer.

Ann Mertens, PhD
Epidemiology and Clinical Research; Pediatrics

Childhood cancer etiology, and late effects in childhood cancer survivors

Antoinette Moran, MD
Endocrinology; Pediatrics

Diabetes mellitus/cystic fibrosis

James Neaton, PhD
Biostatistics; Public Health

Randomized clinical trials - HIV treatment, hypertension, and heart failure trials

Joseph Neglia, MD, MPH
Pediatrics, Division of Hematology/Oncology/Bone Marrow Transplantation

Long-term effects of cancer therapy. Occurrence of second malignancies following childhood cancer.

Thomas Nevins, MD
Nephrology; Pediatrics

Medication compliance, solid organ transplantation, nephrology

Mark Paller, MD, MS
Renal Diseases and Hypertension; Medicine

Clinical trials management; clinical research in acute renal failure, renal and electrolyte disorders

Mark Pereira, MPH, PhD
Epidemiology; Pblic Health

Nutrition and physical activity in the prevention of obesity, type 2 diabetes and cardiovascular disease

Bruce Peterson, MD
Hematology, Oncology, Transplantation; Medicine

Clinical research/Hematologic malignancies

Anna Petryk, MD
Department of Pediatrics

Mammalian development and the molecular mechanisms underlying tissue differentiation and organogenesis.  Endocrine late effects in long term survivors of cancer and/or bone marrow transplantation,

Julie Ross, PhD
Division of Pediatric Epidemology & Clinical Research; Department of Pediatrics

Molecular epidemiology and etiology of malignancies in both children and adults, particularly in the area of leukemia

David Rothenberger, MD
Department of Surgery; Colon/Rectal Surgery

Rectal cancer; Familial Colorectal cancer; Clinical research in a managed care environment

Timothy Schacker, MD
Infectious Diseases and International Health; Medicine

HIV transmission and nature history of Hepes Simplex Virus Infection

S. Charles Schulz, MD
Department of Psychiatry

Schizophrenia, borderline personality disorder, psychiatric illnesses in adolescents, brain imaging

Elizabeth Seaquist, MD
Endocrinology and Diabetes; Medicine

Diabetes and diabetes complications

Julia Steinberger, MD, MS
Pediatrics, Division of Cardiology

Metabolic syndrome  in youth

 

William Thomas, PhD
Biostatistics; Public Health

Clinical trials

Carolyn Torkelson, MD, MS
Family Medicine and Community Health

Complementary/alternative medicine, women’s health, nutrition, probiotics

Todd Tuttle, MD
Surgery, Oncology

Clinical trials evaluating therapies for breast cancer, melanoma, and gastrointestinal malignancies

Daniel Weisdorf, MD
Hematology, Oncology, Transplantation; Medicine

Clinical bone marrow transplantation and management of hematologic malignancy

Mark Yeazel, MD, MPH
Family Practice/Community Health; Medical School

Colorectal cancer screening, Childhood cancer survivors, Clinical research related to cancer prevention and detection

Douglas Yee, MD
Hematology, Oncology, Transplantation; Medicine

Breast cancer: on insulin growth factors (IGF) in breast cancer, including their signaling pathways and receptors

 




Feedback | Notice of Privacy Practices

The University of Minnesota is an equal opportunity educator and employer.